Samenvatting
Samenvatting Les 14 'Biologicals part 2'
Dit document omvat de samenvatting van Les 14 (info slides met notities) van het vak 'Preclinical drug research'.
[Meer zien]Voorbeeld 2 van de 11 pagina's
Voorbeeld 2 van de 11 pagina's
In winkelwagenVerkoper
Volgen
Voorbeeld van de inhoud
Les 14: 6/12- Key differences between pharmaceu5cals and biopharmaceu5cals?
o Manufacturing is the key
o PK is also completely different
o Immunogenicity
§ Small molecules o@en not immunogene5c
o Stability
§ Develop biological: quality control not only during the produc5on of the final
products, but also for tes5ng and evalua5ng the stability
Examples
Vaccines
- Biological, but it is not a classical interven5on
o Why are vaccines more complex then normal biologicals?
§ A vaccine is given before the disease while other drugs are given when you
already have the disease
• To minimize the poten5al impact of the disease
§ Vaccines are given to everyone -> to protect us to the poten5al impact of a
disease => complex situa5on
o We want to s5mulate the immunogenicity with vaccines and that is not the case
with an5bodies
- Most vaccines in the further will be given by nasal spray, by pills or intradermal -> so
no longer injec5ons
- Pox vaccine
o Based on cow pax vaccine
o Before that kind of vaccines were also already administered -> autologous
immuniza5on -> people inoculated with the disease causing agents
- Safety is important
- Most vaccines are prophylac5c, some of them are therapeu5c
o HIV vaccine, cancer vaccine
- Types of vaccines are quite large
o Killed/inac5vated (influenza, hepa55s A)
o AVenuated (measles, rubella, mumps)
o Toxoid (tetanus, diphteria)
o Subunit (Hepa55s B virus, human papillomavirus)
o Conjugate (Haemophilus influenzae type B)
§ Target the glycocalyx capsule; these sugars are important -> IS need to make
ab to bind to the capsule -> neutralize bacteria
§ If you inject saccharides -> not very immunogene5c -> to increase the
immunogenicity you make a conjugate by binding them to a protein
o DNA vaccines
o Vector vaccines
o DC vaccines
- Biological nature
o Star5ng materials
o Manufacturing process
, o Test methods needed to characterize batches
§ Batches in vitro and in vivo
- Vaccine produc5on
o Using prokaryo5c or eukaryo5c micro-organisms
o Subtle changes in these organisms may radically affect the vaccine product.
- Biological characteriza5on (biological assays) should complement physical and
chemical product characteriza5on since not completely understood rela5onships
between
o Physical and chemical characteris5cs
o Immunogenicity and efficacy of these products
o In vitro, but also in animal models
Characteriza5on
Produc'on
- manufacturing process/condi5ons must be highly controlled
o Characteriza5on of batches
o Seed lot system
- Consistency is essen5al
o Consistency is not the same as the exactly the same product
§ It’s need to be consistent for predetermined characteris5cs. You define
this in advance.
- Samples need to be stored from pre-clinical development for later comparison (during
clinical development, a@er upscaling produc5on...)
- Tes5ng physico-chemical parameters: amount of an5gen, size, protein content ~
measure for consistency, but NOT iden5cal
Potency tes'ng
- Measuring biological ac5vity of a vaccine -> look at the immune response
- Not always = mechanism of protec5on in humans
o Animal model -> look for ab induc5on; will it induce ab? How good are the ab?
Etc.
- Way of verifying consistency in manufacturing
o Best way is to use animal model for vaccina5on followed by challenge with
pathogen
§ Vaccinate animals -> challenge with pathogen -> you should see
protec5on
o If no good animal model available, measurement of immune responses
(serology)
§ Induces it a similar immune response as in vitro test?
o Interac5on with known an5bodies
Stability
- Very complex to study ~ complex biological material
o Threshold that you can not loose more then that because you will always loose
some ac5vity -> you need to take this account
- Potency tes5ng and physico-chemical evalua5on is essen5al part of stability tes5ng
- Normal storage temperature, long-term, real-5me storage
- ! Stability of standards and reference materials
o You need even controls for the reference materials -> you do this with other
biologicals
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
√ Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, Bancontact of creditcard voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper evagoormans. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor €7,16. Je zit daarna nergens aan vast.
Is Stuvia te vertrouwen?
4,6 sterren op Google & Trustpilot (+1000 reviews)
Afgelopen 30 dagen zijn er 84251 samenvattingen verkocht
Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen